|
1
|
Boutros PC, Fraser M, Harding NJ, de Borja
R, Trudel D, Lalonde E, Meng A, Hennings-Yeomans PH, McPherson A,
Sabelnykova VY, et al: Spatial genomic heterogeneity within
localized, multifocal prostate cancer. Nat Genet. 47:736–745. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fraser M, Sabelnykova VY, Yamaguchi TN,
Heisler LE, Livingstone J, Huang V, Shiah YJ, Yousif F, Lin X,
Masella AP, et al: Genomic hallmarks of localized, non-indolent
prostate cancer. Nature. 541:359–364. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bi C, Chung TH, Huang G, Zhou J1, Yan J,
Ahmann GJ, Fonseca R and Chng WJ: Genome-wide pharmacologic
unmasking identifies tumor suppressive microRNAs in multiple
myeloma. Oncotarget. 6:26508–26518. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cui Z, Zheng X and Kong D: Decreased
miR-198 expression and its prognostic significance in human gastric
cancer. World J Surg Oncol. 14:332016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu Y, Tang Z, Jiang B, Chen J and Fu Z:
miR-198 functions as a tumor suppressor in breast cancer by
targeting CUB domain-containing protein 1. Oncol Lett.
13:1753–1760. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang WT, Wang HL, Yang H, Ren FH, Luo YH,
Huang CQ, Liang YY, Liang HW, Chen G and Dang YW: Lower expressed
miR-198 and its potential targets in hepatocellular carcinoma: A
clinicopathological and in silico study. Onco Targets Ther.
9:5163–5180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marin-Muller C, Li D, Bharadwaj U, Li M,
Chen C, Hodges SE, Fisher WE, Mo Q, Hung MC and Yao Q: A
tumorigenic factor interactome connected through tumor suppressor
microRNA-198 in human pancreatic cancer. Clin Cancer Res.
19:5901–5913. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nie E, Jin X, Wu W, Yu T, Zhou X, Shi Z,
Zhang J, Liu N and You Y: MiR-198 enhances temozolomide sensitivity
in glioblastoma by targeting MGMT. J Neurooncol. 133:59–68. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang M, Wang J, Kong X, Chen H, Wang Y,
Qin M, Lin Y, Chen H, Xu J, Hong J, et al: MiR-198 represses tumor
growth and metastasis in colorectal cancer by targeting fucosyl
transferase 8. Sci Rep. 4:61452014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu S, Zhang G, Li P, Chen S, Zhang F, Li
J, Jiang C, Chen X, Wang Y, Du Y, et al: miR-198 targets SHMT1 to
inhibit cell proliferation and enhance cell apoptosis in lung
adenocarcinoma. Tumour Biol. 37:5193–5202. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang S, Zhao Y and Wang L: MicroRNA-198
inhibited tumorous behaviors of human osteosarcoma through directly
targeting ROCK1. Biochem Biophys Res Commun. 472:557–565. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu SK, Bham SA, Fokas E, Beech J, Im J,
Cho S, Harris AL and Muschel RJ: Delta-like ligand 4-notch blockade
and tumor radiation response. J Natl Cancer Inst. 103:1778–1798.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dweep H, Sticht C, Pandey P and Gretz N:
miRWalk-database: Prediction of possible miRNA binding sites by
‘walking’ the genes of three genomes. J Biomed Inform. 44:839–847.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mork CN, Faller DV and Spanjaard RA: Loss
of putative tumor suppressor EI24/PIG8 confers resistance to
etoposide. FEBS Lett. 581:5440–5444. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Itoh M, Kim CH, Palardy G, Oda T, Jiang
YJ, Maust D, Yeo SY, Lorick K, Wright GJ, Ariza-McNaughton L, et
al: Mind bomb is a ubiquitin ligase that is essential for efficient
activation of Notch signaling by Delta. Dev Cell. 4:67–82. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ye L, Li S, Ye D, Yang D, Yue F, Guo Y,
Chen X, Chen F, Zhang J and Song X: Livin expression may be
regulated by miR-198 in human prostate cancer cell lines. Eur J
Cancer. 49:734–740. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deng G, Ma L, Meng Q, Ju X, Jiang K, Jiang
P and Yu Z: Notch signaling in the prostate: Critical roles during
development and in the hallmarks of prostate cancer biology. J
Cancer Res Clin Oncol. 142:531–547. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Su Q and Xin L: Notch signaling in
prostate cancer: Refining a therapeutic opportunity. Histol
Histopathol. 31:149–157. 2016.PubMed/NCBI
|
